Literature DB >> 10584677

Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause.

I Vermes1, E N Steur, C Reutelingsperger, C Haanen.   

Abstract

Circumstantial evidence suggests that increased apoptosis is responsible for the loss of dopaminergic nigrostriatal neurons in Parkinson's disease (PD). It is impossible to perform high-quality studies on human postmortem material because of the low quality of tissue preservation, and the fact that apoptosis has a duration of only hours, and that the duration of the agonal period itself will lead to massive neuronal cell death. We measured, as epiphenomenon of neuronal cell death ex vivo, the Annexin V concentration in cerebrospinal fluid (CSF) in patients with PD and control subjects. The Annexin V concentration in CSF of patients with PD was significantly lower compared with control subjects. Annexin V concentrations of the CSF did not correlate with dementia, duration of symptoms, age, sex, or treatment of PD. The rationale for measurement of Annexin V in CSF is the fact that Annexin V adheres to dying cells. It is tempting to suppose that the decrease of Annexin V in CSF of PD is the result of consumption of this protein during neuronal apoptosis as has been demonstrated to occur in the midbrain in PD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10584677     DOI: 10.1002/1531-8257(199911)14:6<1008::aid-mds1015>3.0.co;2-e

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Proteomics analysis of MPP+-induced apoptosis in SH-SY5Y cells.

Authors:  Hongrong Xie; Ming Chang; Xinyu Hu; Danping Wang; Mingxiu Tian; Guoyi Li; Huiyi Jiang; Ying Wang; Zhong Dong; Yuhua Zhang; Linsen Hu
Journal:  Neurol Sci       Date:  2010-06-19       Impact factor: 3.307

Review 2.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

Review 3.  Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.

Authors:  Karin D van Dijk; Charlotte E Teunissen; Benjamin Drukarch; Connie R Jimenez; Henk J Groenewegen; Henk W Berendse; Wilma D J van de Berg
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

4.  Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer's disease.

Authors:  Fernando Bartolome; Agnieszka Krzyzanowska; Macarena de la Cueva; Consuelo Pascual; Desiree Antequera; Carlos Spuch; Alberto Villarejo-Galende; Alberto Rabano; Juan Fortea; Daniel Alcolea; Alberto Lleo; Isidro Ferrer; John Hardy; Andrey Y Abramov; Eva Carro
Journal:  Sci Rep       Date:  2020-06-10       Impact factor: 4.379

5.  Proteome analysis of human substantia nigra in Parkinson's disease.

Authors:  Cornelius J Werner; Roland Heyny-von Haussen; Gerhard Mall; Sabine Wolf
Journal:  Proteome Sci       Date:  2008-02-14       Impact factor: 2.480

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.